Financhill
Sell
49

CLBT Quote, Financials, Valuation and Earnings

Last price:
$19.39
Seasonality move :
15.17%
Day range:
$19.69 - $20.04
52-week range:
$10.25 - $26.30
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
10.29x
P/B ratio:
14.05x
Volume:
1M
Avg. volume:
978.6K
1-year change:
83.86%
Market cap:
$4.7B
Revenue:
$401.2M
EPS (TTM):
-$1.39

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
CLBT
Cellebrite DI
$109.4M $0.09 20.5% 195.1% $27.57
CYBR
CyberArk Software
$305.6M $0.79 37.93% 506.05% $435.17
FORTY
Formula Systems (1985)
-- -- -- -- --
NVMI
Nova
$211.2M $2.09 48.17% 79.98% $279.59
SATX
SatixFy Communications
$3.5M -$0.12 83.63% -14.29% $2.50
SYNX
Silynxcom
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
CLBT
Cellebrite DI
$19.71 $27.57 $4.7B -- $0.00 0% 10.29x
CYBR
CyberArk Software
$364.63 $435.17 $18B 1,479.68x $0.00 0% 16.97x
FORTY
Formula Systems (1985)
$87.00 -- $1.3B 17.09x $0.94 1.8% 0.49x
NVMI
Nova
$196.07 $279.59 $5.7B 34.16x $0.00 0% 9.35x
SATX
SatixFy Communications
$2.02 $2.50 $175.4M -- $0.00 0% 8.20x
SYNX
Silynxcom
$1.76 -- $8.9M -- $0.00 0% --
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
CLBT
Cellebrite DI
-- 0.878 -- 1.79x
CYBR
CyberArk Software
-- 1.651 -- 1.42x
FORTY
Formula Systems (1985)
41.37% 0.080 23.11% 1.28x
NVMI
Nova
16.29% 2.562 3.13% 1.87x
SATX
SatixFy Communications
-305.75% -2.670 115.09% 0.28x
SYNX
Silynxcom
-- -0.446 -- --
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
CLBT
Cellebrite DI
$91.4M $15.7M -235.18% -235.18% 14.42% $61.7M
CYBR
CyberArk Software
$240.6M -$31.4M -5.59% -7.65% 8.95% $60.8M
FORTY
Formula Systems (1985)
$180.5M $71.9M 4.33% 5.95% 10.39% --
NVMI
Nova
$109.9M $55.5M 17.69% 21.77% 28.48% $60.4M
SATX
SatixFy Communications
$1.7M -$9.4M -- -- -382.33% --
SYNX
Silynxcom
-- -- -- -- -- --

Cellebrite DI vs. Competitors

  • Which has Higher Returns CLBT or CYBR?

    CyberArk Software has a net margin of 17.67% compared to Cellebrite DI's net margin of -30.89%. Cellebrite DI's return on equity of -235.18% beat CyberArk Software's return on equity of -7.65%.

    Company Gross Margin Earnings Per Share Invested Capital
    CLBT
    Cellebrite DI
    83.84% $0.08 $336M
    CYBR
    CyberArk Software
    76.54% -$2.02 $2.4B
  • What do Analysts Say About CLBT or CYBR?

    Cellebrite DI has a consensus price target of $27.57, signalling upside risk potential of 39.89%. On the other hand CyberArk Software has an analysts' consensus of $435.17 which suggests that it could grow by 19.35%. Given that Cellebrite DI has higher upside potential than CyberArk Software, analysts believe Cellebrite DI is more attractive than CyberArk Software.

    Company Buy Ratings Hold Ratings Sell Ratings
    CLBT
    Cellebrite DI
    6 0 0
    CYBR
    CyberArk Software
    27 2 0
  • Is CLBT or CYBR More Risky?

    Cellebrite DI has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison CyberArk Software has a beta of 0.988, suggesting its less volatile than the S&P 500 by 1.239%.

  • Which is a Better Dividend Stock CLBT or CYBR?

    Cellebrite DI has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CyberArk Software offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cellebrite DI pays -- of its earnings as a dividend. CyberArk Software pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CLBT or CYBR?

    Cellebrite DI quarterly revenues are $109M, which are smaller than CyberArk Software quarterly revenues of $314.4M. Cellebrite DI's net income of $19.3M is higher than CyberArk Software's net income of -$97.1M. Notably, Cellebrite DI's price-to-earnings ratio is -- while CyberArk Software's PE ratio is 1,479.68x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cellebrite DI is 10.29x versus 16.97x for CyberArk Software. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CLBT
    Cellebrite DI
    10.29x -- $109M $19.3M
    CYBR
    CyberArk Software
    16.97x 1,479.68x $314.4M -$97.1M
  • Which has Higher Returns CLBT or FORTY?

    Formula Systems (1985) has a net margin of 17.67% compared to Cellebrite DI's net margin of 2.9%. Cellebrite DI's return on equity of -235.18% beat Formula Systems (1985)'s return on equity of 5.95%.

    Company Gross Margin Earnings Per Share Invested Capital
    CLBT
    Cellebrite DI
    83.84% $0.08 $336M
    FORTY
    Formula Systems (1985)
    26.1% $1.28 $1.9B
  • What do Analysts Say About CLBT or FORTY?

    Cellebrite DI has a consensus price target of $27.57, signalling upside risk potential of 39.89%. On the other hand Formula Systems (1985) has an analysts' consensus of -- which suggests that it could fall by --. Given that Cellebrite DI has higher upside potential than Formula Systems (1985), analysts believe Cellebrite DI is more attractive than Formula Systems (1985).

    Company Buy Ratings Hold Ratings Sell Ratings
    CLBT
    Cellebrite DI
    6 0 0
    FORTY
    Formula Systems (1985)
    0 0 0
  • Is CLBT or FORTY More Risky?

    Cellebrite DI has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Formula Systems (1985) has a beta of 0.876, suggesting its less volatile than the S&P 500 by 12.37%.

  • Which is a Better Dividend Stock CLBT or FORTY?

    Cellebrite DI has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Formula Systems (1985) offers a yield of 1.8% to investors and pays a quarterly dividend of $0.94 per share. Cellebrite DI pays -- of its earnings as a dividend. Formula Systems (1985) pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CLBT or FORTY?

    Cellebrite DI quarterly revenues are $109M, which are smaller than Formula Systems (1985) quarterly revenues of $691.5M. Cellebrite DI's net income of $19.3M is lower than Formula Systems (1985)'s net income of $20.1M. Notably, Cellebrite DI's price-to-earnings ratio is -- while Formula Systems (1985)'s PE ratio is 17.09x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cellebrite DI is 10.29x versus 0.49x for Formula Systems (1985). Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CLBT
    Cellebrite DI
    10.29x -- $109M $19.3M
    FORTY
    Formula Systems (1985)
    0.49x 17.09x $691.5M $20.1M
  • Which has Higher Returns CLBT or NVMI?

    Nova has a net margin of 17.67% compared to Cellebrite DI's net margin of 25.92%. Cellebrite DI's return on equity of -235.18% beat Nova's return on equity of 21.77%.

    Company Gross Margin Earnings Per Share Invested Capital
    CLBT
    Cellebrite DI
    83.84% $0.08 $336M
    NVMI
    Nova
    56.44% $1.58 $1.1B
  • What do Analysts Say About CLBT or NVMI?

    Cellebrite DI has a consensus price target of $27.57, signalling upside risk potential of 39.89%. On the other hand Nova has an analysts' consensus of $279.59 which suggests that it could grow by 42.6%. Given that Nova has higher upside potential than Cellebrite DI, analysts believe Nova is more attractive than Cellebrite DI.

    Company Buy Ratings Hold Ratings Sell Ratings
    CLBT
    Cellebrite DI
    6 0 0
    NVMI
    Nova
    6 1 0
  • Is CLBT or NVMI More Risky?

    Cellebrite DI has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Nova has a beta of 1.659, suggesting its more volatile than the S&P 500 by 65.934%.

  • Which is a Better Dividend Stock CLBT or NVMI?

    Cellebrite DI has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nova offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cellebrite DI pays -- of its earnings as a dividend. Nova pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CLBT or NVMI?

    Cellebrite DI quarterly revenues are $109M, which are smaller than Nova quarterly revenues of $194.8M. Cellebrite DI's net income of $19.3M is lower than Nova's net income of $50.5M. Notably, Cellebrite DI's price-to-earnings ratio is -- while Nova's PE ratio is 34.16x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cellebrite DI is 10.29x versus 9.35x for Nova. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CLBT
    Cellebrite DI
    10.29x -- $109M $19.3M
    NVMI
    Nova
    9.35x 34.16x $194.8M $50.5M
  • Which has Higher Returns CLBT or SATX?

    SatixFy Communications has a net margin of 17.67% compared to Cellebrite DI's net margin of -539.62%. Cellebrite DI's return on equity of -235.18% beat SatixFy Communications's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    CLBT
    Cellebrite DI
    83.84% $0.08 $336M
    SATX
    SatixFy Communications
    67.59% -$0.16 -$22.6M
  • What do Analysts Say About CLBT or SATX?

    Cellebrite DI has a consensus price target of $27.57, signalling upside risk potential of 39.89%. On the other hand SatixFy Communications has an analysts' consensus of $2.50 which suggests that it could grow by 23.76%. Given that Cellebrite DI has higher upside potential than SatixFy Communications, analysts believe Cellebrite DI is more attractive than SatixFy Communications.

    Company Buy Ratings Hold Ratings Sell Ratings
    CLBT
    Cellebrite DI
    6 0 0
    SATX
    SatixFy Communications
    2 0 0
  • Is CLBT or SATX More Risky?

    Cellebrite DI has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison SatixFy Communications has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock CLBT or SATX?

    Cellebrite DI has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SatixFy Communications offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cellebrite DI pays -- of its earnings as a dividend. SatixFy Communications pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CLBT or SATX?

    Cellebrite DI quarterly revenues are $109M, which are larger than SatixFy Communications quarterly revenues of $2.5M. Cellebrite DI's net income of $19.3M is higher than SatixFy Communications's net income of -$13.3M. Notably, Cellebrite DI's price-to-earnings ratio is -- while SatixFy Communications's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cellebrite DI is 10.29x versus 8.20x for SatixFy Communications. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CLBT
    Cellebrite DI
    10.29x -- $109M $19.3M
    SATX
    SatixFy Communications
    8.20x -- $2.5M -$13.3M
  • Which has Higher Returns CLBT or SYNX?

    Silynxcom has a net margin of 17.67% compared to Cellebrite DI's net margin of --. Cellebrite DI's return on equity of -235.18% beat Silynxcom's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    CLBT
    Cellebrite DI
    83.84% $0.08 $336M
    SYNX
    Silynxcom
    -- -- --
  • What do Analysts Say About CLBT or SYNX?

    Cellebrite DI has a consensus price target of $27.57, signalling upside risk potential of 39.89%. On the other hand Silynxcom has an analysts' consensus of -- which suggests that it could grow by 354.55%. Given that Silynxcom has higher upside potential than Cellebrite DI, analysts believe Silynxcom is more attractive than Cellebrite DI.

    Company Buy Ratings Hold Ratings Sell Ratings
    CLBT
    Cellebrite DI
    6 0 0
    SYNX
    Silynxcom
    0 0 0
  • Is CLBT or SYNX More Risky?

    Cellebrite DI has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Silynxcom has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock CLBT or SYNX?

    Cellebrite DI has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Silynxcom offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cellebrite DI pays -- of its earnings as a dividend. Silynxcom pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CLBT or SYNX?

    Cellebrite DI quarterly revenues are $109M, which are larger than Silynxcom quarterly revenues of --. Cellebrite DI's net income of $19.3M is higher than Silynxcom's net income of --. Notably, Cellebrite DI's price-to-earnings ratio is -- while Silynxcom's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cellebrite DI is 10.29x versus -- for Silynxcom. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CLBT
    Cellebrite DI
    10.29x -- $109M $19.3M
    SYNX
    Silynxcom
    -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Berkshire The Best Stock to Buy in a Bad Market?
Is Berkshire The Best Stock to Buy in a Bad Market?

Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…

Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?

The big picture trends in e‑commerce sales are clearly in…

Is RTX The Best Growth Stock?
Is RTX The Best Growth Stock?

Among the worldwide aerospace and defense markets, the US controls…

Stock Ideas

Buy
71
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
63
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
60
RGC alert for May 6

Regencell Bioscience Holdings [RGC] is up 153.01% over the past day.

Buy
63
SKX alert for May 6

Skechers USA [SKX] is down 0% over the past day.

Sell
20
PTCT alert for May 6

PTC Therapeutics [PTCT] is down 5.95% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock